Physician
Treasure Coast Pathology, PA
Treasure Coast Pathology, PA was paid $2.72M by Medicaid between Jan 2018 and Nov 2024, across 121 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 40% of everything it billed.
33Billing provider infoTREASURE COAST PATHOLOGY, PA
STUART, FL 34994
STUART, FL 34994
33aNPI1437454964assigned 01/13/2011
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.72M
24GClaims650,331
24DCodes billed121
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#10 of 207
Median peer was paid$39K
This provider vs. median69×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,628 | $47K | |
| 2019 | 125,943 | $237K | |
| 2020 | 97,778 | $289K | |
| 2021 | 111,857 | $553K | |
| 2022 | 121,612 | $753K | |
| 2023 | 96,114 | $591K | |
| 2024incomplete | 52,399 | $254K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 40% | 4,168 | 3,995 | $1.10M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 9.4% | 3,211 | 3,102 | $257K |
| 87486 | 5.4% | 10,734 | 10,250 | $147K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.9% | 6,601 | 6,182 | $107K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.6% | 2,488 | 2,270 | $97K |
| 80053 | Comprehensive metabolic panel | 3.1% | 44,043 | 27,213 | $83K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.9% | 7,940 | 4,812 | $80K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.7% | 8,457 | 8,192 | $75K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.6% | 44,344 | 25,165 | $71K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2.5% | 9,590 | 8,659 | $68K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 72,319 | 44,754 | $54K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.7% | 1,269 | 1,159 | $45K |
109 more codes
| 87581 | 1.6% | 10,713 | $43K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.6% | 3,663 | $42K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.2% | 809 | $34K |
| 82962 | 1.2% | 28,385 | $33K | |
| 87040 | 1.0% | 11,710 | $28K | |
| 84484 | <1% | 14,469 | $24K | |
| 82805 | <1% | 2,240 | $22K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,334 | $19K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,400 | $17K |
| 85027 | <1% | 26,245 | $16K | |
| 83735 | <1% | 22,969 | $16K | |
| 83605 | <1% | 13,608 | $16K | |
| 83880 | <1% | 1,899 | $14K | |
| 81001 | <1% | 30,430 | $14K | |
| 84702 | <1% | 3,572 | $12K | |
| 87634 | <1% | 3,740 | $12K | |
| 83690 | <1% | 17,903 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,304 | $9K |
| 86850 | <1% | 6,540 | $9K | |
| 80076 | <1% | 13,277 | $9K | |
| 86900 | <1% | 14,328 | $8K | |
| 87088 | <1% | 11,100 | $8K | |
| 80061 | Lipid panel | <1% | 3,129 | $8K |
| 85576 | <1% | 1,898 | $7K | |
| 84100 | <1% | 13,165 | $6K | |
| 87070 | <1% | 6,241 | $6K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,331 | $6K |
| 82550 | <1% | 8,740 | $5K | |
| 86140 | <1% | 11,243 | $5K | |
| 85730 | <1% | 10,189 | $5K | |
| 85610 | <1% | 13,497 | $5K | |
| 84703 | <1% | 6,358 | $4K | |
| 87186 | <1% | 4,264 | $4K | |
| 86901 | <1% | 11,543 | $4K | |
| 82948 | <1% | 5,111 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,885 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,576 | $4K |
| 82150 | <1% | 7,191 | $4K | |
| 82553 | <1% | 4,948 | $3K | |
| 82247 | <1% | 3,526 | $3K | |
| 85379 | <1% | 4,267 | $3K | |
| 81003 | <1% | 11,073 | $3K | |
| 81025 | <1% | 2,649 | $3K | |
| 87205 | <1% | 3,708 | $2K | |
| 80202 | <1% | 1,285 | $2K | |
| 84030 | <1% | 3,194 | $2K | |
| 82248 | <1% | 3,231 | $2K | |
| 82140 | <1% | 948 | $2K | |
| 85652 | <1% | 4,674 | $1K | |
| 82728 | <1% | 1,151 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,731 | $1K |
| 87077 | <1% | 1,005 | $1K | |
| 84145 | <1% | 3,820 | $1K | |
| 87807 | <1% | 907 | $1K | |
| 80074 | <1% | 158 | $1K | |
| 86886 | <1% | 2,889 | $977.32 | |
| 86880 | <1% | 1,290 | $816.64 | |
| 85018 | <1% | 3,728 | $794.59 | |
| 82607 | <1% | 349 | $698.24 | |
| 85046 | <1% | 1,227 | $671.47 | |
| 87210 | <1% | 1,493 | $587.52 | |
| 85014 | <1% | 3,210 | $586.75 | |
| 86592 | <1% | 2,037 | $583.08 | |
| 82010 | <1% | 425 | $506.28 | |
| 83615 | <1% | 1,041 | $455.20 | |
| 83540 | <1% | 743 | $441.87 | |
| 80069 | <1% | 455 | $434.02 | |
| 82330 | <1% | 241 | $422.53 | |
| 83550 | <1% | 572 | $419.92 | |
| 87081 | <1% | 1,601 | $411.29 | |
| 82570 | <1% | 653 | $369.34 | |
| 84439 | <1% | 348 | $204.16 | |
| 84156 | <1% | 494 | $193.95 | |
| 82375 | <1% | 203 | $184.48 | |
| 82746 | <1% | 150 | $177.09 | |
| 85380 | <1% | 320 | $166.38 | |
| 84550 | <1% | 246 | $127.97 | |
| 82270 | <1% | 232 | $123.52 | |
| 88342 | <1% | 14 | $113.35 | |
| 80047 | <1% | 15 | $108.80 | |
| 87340 | <1% | 105 | $102.82 | |
| 88304 | <1% | 13 | $89.10 | |
| 86308 | <1% | 234 | $88.22 | |
| 83050 | <1% | 209 | $84.67 | |
| 87507 | <1% | 14 | $81.61 | |
| 87015 | <1% | 87 | $81.27 | |
| 87641 | <1% | 26 | $68.66 | |
| 87116 | <1% | 90 | $65.66 | |
| 80320 | <1% | 98 | $64.53 | |
| 87147 | <1% | 87 | $59.64 | |
| 84132 | <1% | 284 | $57.52 | |
| 87206 | <1% | 116 | $53.40 | |
| 87075 | <1% | 40 | $50.85 | |
| 82947 | <1% | 97 | $29.65 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $29.38 |
| 82077 | <1% | 941 | $27.29 | |
| 85045 | <1% | 42 | $25.87 | |
| 84295 | <1% | 109 | $22.30 | |
| 80329 | <1% | 28 | $18.99 | |
| 82435 | <1% | 66 | $12.79 | |
| 85384 | <1% | 36 | $11.70 | |
| 85007 | <1% | 18 | $10.70 | |
| 80179 | <1% | 13 | $8.13 | |
| 80143 | <1% | 14 | $7.75 | |
| 89051 | <1% | 16 | $7.12 | |
| 84300 | <1% | 13 | $4.55 | |
| 87102 | <1% | 17 | $2.76 | |
| 86780 | <1% | 65 | $2.15 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSINGH, ANITA (AUTHORIZED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Anita C. Singh, DDS, INC | Lake Elsinore, CA | $626K |
| Treasure Coast Pathology, PA | Port St Lucie, FL | $81K |
| Treasure Coast Pathology, PA | Stuart, FL | $28K |
| Treasure Coast Pathology, PA | Port St Lucie, FL | $21K |
| Treasure Coast Pathology, PA | Jupiter, FL | $17K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.